{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:52:54Z","timestamp":1768967574637,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002121","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T00:00:00Z","timestamp":1440374400000},"record-id":"31938"},{"DOI":"10.1002\/14651858.cd002121","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T00:00:00Z","timestamp":1440374400000}}],"reference-count":52,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002121.pub2","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T08:19:18Z","timestamp":1440404358000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome"],"prefix":"10.1002","volume":"2015","author":[{"given":"Marleen","family":"Nahuis","sequence":"first","affiliation":[{"name":"Medisch Spectrum Twente; Enschede Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neriman","family":"Bayram","sequence":"additional","affiliation":[{"name":"Zaans Medisch Centrum; Department of Obstetrics and Gynaecology; koningin Julianaplein 58 Zaandam Netherlands 1502 DV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulco","family":"Van der Veen","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,8,24]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD002121.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1023\/A:1026433813702","article-title":"Recombinant Human Follicle-Stimulating Hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low dose step up protocol.","volume":"17","author":"Balasch","year":"2000","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"4","key":"10.1002\/14651858.CD002121.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/humrep\/16.4.652","article-title":"Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovary syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.","volume":"16","author":"Balasch","year":"2001","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD002121.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/humrep\/dem075","article-title":"Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomised controlled non-inferiority trial.","volume":"22","author":"Balan","year":"2007","journal-title":"Human reproduction"},{"issue":"8","key":"10.1002\/14651858.CD002121.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A comparative randomized multicentric study comparing the step up versus step-down protocol in polycystic ovary syndrome.","volume":"18","author":"Christin Maitre","year":"2003","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD002121.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(97)00423-8","article-title":"Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial","volume":"69","author":"Coelingh Bennink","year":"1998","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD002121.pub2-BIB6|cit6","first-page":"297","article-title":"A new highly purified human-derived FSH, Bravelle, is as effective and well tolerated as recombinant follitropin beta in ovulation induction in infertile women with ovulatory dysfunction","volume":"19","author":"Feigenbaum","year":"2001","journal-title":"Today's Therapeutic Trends"},{"issue":"5","key":"10.1002\/14651858.CD002121.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1472-6483(10)61632-X","article-title":"Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patinets: a prospective randomised analysis of cost effectiveness.","volume":"9","author":"Gerli","year":"2004","journal-title":"Reproductive biomedicine Online"},{"issue":"S1","key":"10.1002\/14651858.CD002121.pub2-BIB8|cit8","first-page":"xviii2","article-title":"Comparison of two different low dose step up regimens of recombinant FSH in polycystic ovary disease patients","volume":"18","author":"Gurgan","year":"2003","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD002121.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/humrep\/13.10.2688","article-title":"A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women","volume":"13","author":"Hedon","year":"1998","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD002121.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/humrep\/del265","article-title":"The use of decremental dose regimen in patients treated with a chronic low dose step-up protocol for WHO group II anovulation: a prospective randomized multicentre study.","volume":"21","author":"Hugues","year":"2006","journal-title":"Human reproduction"},{"issue":"6","key":"10.1002\/14651858.CD002121.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.fertnstert.2005.11.049","article-title":"Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone","volume":"85","author":"Leader","year":"2006","journal-title":"Fertility & Sterility"},{"issue":"1","key":"10.1002\/14651858.CD002121.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/11.suppl_5.95","article-title":"Clinical assessment of human gonadotrophins produced by recombinant DNA technology","volume":"11 Suppl","author":"Loumaye","year":"1996","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD002121.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/humrep\/del085","article-title":"Similar ovulation rates but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study.","volume":"21","author":"Platteau","year":"2006","journal-title":"human reproduction"},{"key":"10.1002\/14651858.CD002121.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-7827-4-38","article-title":"Recombinant versus highly purified, urinary follicle stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective randomized study with cost minimization analysis.","volume":"4","author":"Revelli","year":"2006","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD002121.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/09513590310001651731","article-title":"Low-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome.","volume":"18","author":"Sziligayi","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1002\/14651858.CD002121.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12522-009-0044-7","article-title":"Recombinant follicle stimulating hormone (follitropin alfa) for ovulation induction in japanese patients with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a phase II dose response study.","volume":"9","author":"Taketani","year":"2009","journal-title":"Reprod Med Biol"},{"key":"10.1002\/14651858.CD002121.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12522-010-0046-5","article-title":"Recombinant follicle stimulating hormone (follitropin alfa) versus purified urinary follicle stimulating hormone in a low dose step up regimen to induce ovualtion in japanese women with anti-estrogen-ineffective oligo- or anovulatory infertility","volume":"9","author":"Taketani","year":"2010","journal-title":"Reprod Med Biol"},{"issue":"2","key":"10.1002\/14651858.CD002121.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0015-0282(99)00209-5","article-title":"Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study","volume":"72","author":"Yarali","year":"1999","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD002121.pub2-BIB19|cit19","first-page":"172","article-title":"Effectiveness and cost-effectiveness of urinary FSH versus recombinant FSH in clomiphene citrate-resistant anovulatory infertile patients: opposing the policy of abandoning the use of urinary FSH","volume":"8","author":"Attia","year":"2003","journal-title":"Middle East Fertility Society Journal"},{"issue":"5","key":"10.1002\/14651858.CD002121.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000050000","article-title":"Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment","volume":"55","author":"Fulghesu","year":"2001","journal-title":"Hormone research\u00a0"},{"issue":"4","key":"10.1002\/14651858.CD002121.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.fertnstert.2008.01.004","article-title":"Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination","volume":"91","author":"Kabli","year":"2009","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD002121.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1472-6483(10)60128-9","article-title":"Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome","volume":"18","author":"Lan","year":"2009","journal-title":"Reproductive BioMedicine Online"},{"issue":"8","key":"10.1002\/14651858.CD002121.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/oxfordjournals.humrep.a019459","article-title":"Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a women with a history of allergic reaction to human menopausal gonadotrophin","volume":"11","author":"Albano","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002121.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-4157(88)90012-3","article-title":"Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin","volume":"947","author":"Baenziger","year":"1988","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD002121.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/oxfordjournals.humrep.a138750","article-title":"Cumulative conception and live birth rates after the treatment of anovulatory infertility. An analysis of the safety and efficacy of ovulation induction in 200 patients","volume":"9","author":"Balen","year":"1994","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD002121.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/oxfordjournals.humrep.a138345","article-title":"Allergenic potential of gonadotrophic preparations in experimental animal: Relevance of purity","volume":"9","author":"Biffoni","year":"1994","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002121.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-0528.1969.tb05837.x","article-title":"Factors involved in the induction of fertile ovulation with human gonadotrophins","volume":"76","author":"Brown","year":"1969","journal-title":"Journal of Obstetrics & Gynaecology of the British Commonwealth"},{"issue":"2","key":"10.1002\/14651858.CD002121.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/humrep\/dem305","article-title":"Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis","volume":"23","author":"Coomarasamy","year":"2008","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1002\/14651858.CD002121.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/molehr\/2.5.361","article-title":"Structure-function relationschip of recombinant follicle stimulating hormene (Puregon)","volume":"2","author":"Leeuw","year":"1996","journal-title":"Molecular Human Reproduction"},{"key":"10.1002\/14651858.CD002121.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0950-3552(05)80133-6","article-title":"The step-down principle in gonadotrohin treatment and the role of GnRH analogues","volume":"7","author":"Fauser","year":"1993","journal-title":"Baillieres Best Practice Research in Clinical Obstetrics Gynaecology"},{"key":"10.1002\/14651858.CD002121.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9378(85)90154-1","article-title":"Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome","volume":"151","author":"Garcea","year":"1985","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD002121.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jcem-18-12-1333","article-title":"Clinical effect of human pituitary follicle stimulating hormone","volume":"18","author":"Gemzell","year":"1958","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"288","key":"10.1002\/14651858.CD002121.pub2-BIB33|cit33","first-page":"20","article-title":"Glycoprotein gonadotrophins. Structure and synthesis","volume":"119 Suppl","author":"Gray","year":"1988","journal-title":"Acta Endocrinology"},{"key":"10.1002\/14651858.CD002121.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/oxfordjournals.humrep.a137491","article-title":"Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome","volume":"6","author":"Hamilton-Fairley","year":"1991","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD002121.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1432-1033.1990.tb19332.x","article-title":"Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin (hFSH) expressed in Chinese Hamster ovary cells","volume":"193","author":"Hard","year":"1990","journal-title":"European Journal of Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD002121.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-0528.1999.tb08230.x","article-title":"Recombinant gonadotrophins","volume":"106","author":"Hayden","year":"1999","journal-title":"British Journal of Obstetrics & Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD002121.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/5.5.493","article-title":"Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements","volume":"5","author":"Homburg","year":"1999","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD002121.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/humupd\/2.2.172","article-title":"Genetic Engineering of human FSH (Gonal F)","volume":"2","author":"Howles","year":"1996","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD002121.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynaecological Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD002121.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/S0021-9258(18)83656-0","article-title":"Expression of biologically active human follitropin in Chinese hamster ovary cells","volume":"264","author":"Keene","year":"1989","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1002\/14651858.CD002121.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/oxfordjournals.humrep.a136208","article-title":"In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP","volume":"10","author":"Lambert","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002121.pub2-BIB42|cit42","first-page":"213","article-title":"Effetti clinici della gonadotropina umana della post-menopausa","volume":"59","author":"Lunenfeld","year":"1960","journal-title":"Rass Clin Terap"},{"key":"10.1002\/14651858.CD002121.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2265.1974.tb01799.x","article-title":"Classification of amenorrhoeic states and their treatment by ovulation induction","volume":"3","author":"Lunenfeld","year":"1974","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD002121.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/oxfordjournals.humrep.a137309","article-title":"Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy","volume":"6","author":"Neyro","year":"1991","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD002121.pub2-BIB45|cit45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000410","article-title":"Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome","author":"Nugent","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002121.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(16)54351-9","article-title":"Polycystic ovary syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle stimulating hormone","volume":"55","author":"Shoham","year":"1991","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD002121.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj2870665","article-title":"Molecular structures of glycoprotein hormones and functions of their carbohydrate components","volume":"287","author":"Stockell Hartree","year":"1992","journal-title":"Biochemistry Journal"},{"key":"10.1002\/14651858.CD002121.pub2-BIB48|cit48","article-title":"Recombinant versus urinary derived gonadotrophins for ovarian stimulation in in vitro fertilisation and intra-cytoplasmic sperm injection cycles","author":"Wely","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002121.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.humrep.a138147","article-title":"Pharmacodynamics of human menopausal gonadotrophin (HMG) and follicle stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease","volume":"8","author":"Weissenbruch","year":"1993","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002121.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0015-0282(16)44711-4","article-title":"The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease","volume":"33","author":"Wang","year":"1980","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD002121.pub2-BIB51|cit51","first-page":"43","article-title":"Isoforms of human gonadotrophins under different physiological conditions","volume-title":"Gonadotrophin isoforms: facts and future","author":"Wide","year":"1997"},{"key":"10.1002\/14651858.CD002121.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1677\/joe.0.1250003","article-title":"Gonadotrophin glycosylation and function","volume":"125","author":"Wilson","year":"1990","journal-title":"Journal of Endocrinology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002121.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T12:33:56Z","timestamp":1703162036000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002121.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,24]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002121.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,24]]}}}